In CRC such aberrant hypermethylation has been observed in the promoters of key tumor-suppressor genes, such as cyclin-dependent kinase inhibitor 2A (CDKN2A), MutL protein homolog 1 (MLH1), and APC [22]. The gene discussed is APC; the disease is colorectal carcinoma.